Scott Wardwell
Impact in
- Immunology top 5%
- Immune Response and Inflammation
- interferon and immune responses
- Molecular Biology top 5%
- Cell death mechanisms and regulation
- Inflammasome and immune disorders
- Fibroblast Growth Factor Research
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 3
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Victor M. Rivera (16 shared papers)Tim Clackson (14 shared papers)Frank Wang (12 shared papers)Winnie W. Wong (1 shared paper)E. Gene Towne (1 shared paper)Robert Kamen (1 shared paper)Subhashis Banerjee (1 shared paper)Simon Franklin (1 shared paper)
- Journals
- Cancer Research (5 papers)Molecular Cancer Therapeutics (4 papers)Blood (4 papers)Clinical Cancer Research (1 paper)International Journal of Oncology (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Scott Wardwell
22 papers receiving 2.5k citations
Scott Wardwell's Hit Papers
Peers
Comparison fields: 5 of 101
- Immunology 636
- Molecular Biology 1.5k
- Hematology 237
- Gastroenterology 93
- Genetics 141
Countries citing papers authored by Scott Wardwell
This map shows the geographic impact of Scott Wardwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Wardwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Wardwell more than expected).
Fields of papers citing papers by Scott Wardwell
This network shows the impact of papers produced by Scott Wardwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Wardwell. The network helps show where Scott Wardwell may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Wardwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock Hit paper breakdown → | 1995 | 1277 |
| 2 | 2012 | 283 | |
| 3 | 2000 | 280 | |
| 4 | 2014 | 128 | |
| 5 | 2011 | 114 | |
| 6 | 2011 | 89 | |
| 7 | 2013 | 53 | |
| 8 | 2005 | 52 | |
| 9 | 2010 | 44 | |
| 10 | 2011 | 42 | |
| 11 | 2012 | 37 | |
| 12 | 1990 | 28 | |
| 13 | 2012 | 27 | |
| 14 | 2018 | 19 | |
| 15 | 2007 | 16 | |
| 16 | Effect of butyrate and corticosteroids on retinoblastoma in vitro and in vivo. | 1991 | 12 |
| 17 | 2015 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2008 | 7 | |
| 20 | 2015 | 3 |
About Scott Wardwell
Scott Wardwell is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Hematology and Cancer Research, having authored 22 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Mast cells and histamine (3 papers), Eosinophilic Disorders and Syndromes (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer Genomics and Diagnostics (2 papers) and Fungal Plant Pathogen Control (2 papers). The work is most often cited by research in Immunology (636 citations), Molecular Biology (1.5k citations), Hematology (237 citations), Gastroenterology (93 citations) and Genetics (141 citations). Scott Wardwell has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Victor M. Rivera, Tim Clackson, Frank Wang, Winnie W. Wong, E. Gene Towne, Robert Kamen, Subhashis Banerjee, Simon Franklin, Tara Seshadri and J. J. McDowell. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Blood, Clinical Cancer Research and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.